Clinical Trial

PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

Name: PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS — clinical trial record (NCT06391905)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to preliminarily observe the efficacy and safety of PCSK9 inhibitors in combination with standard advanced first-line regimens in the treatment of advanced colorectal cancer with pMMR/MSS.

Trial Details

NCT Number	NCT06391905
Lead Sponsor	Guangdong Provincial People's Hospital
Conditions	Colorectal Cancer
Enrollment	60 participants
Start Date	2024-05-06
Primary Completion	2028-04-06 (estimated)
Study Completion	2028-05-06 (estimated)
Updated on ClinicalTrials.gov	2024-04-30